Plasma levels of α1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients

Börner, Friedemann RLechowicz, UrszulaWrenger, SabineMartinez-Delgado, BeatrizOlejnicka, BeataWelte, TobiasChorostowska-Wynimko, JoannaKiehntopf, MichaelJanciauskiene, Sabina2024-01-312024-01-312023-11ERJ Open Res. 2023 Dec 4;9(6):00329-2023.2312-0541http://hdl.handle.net/20.500.12105/17381Plasma levels of α1-antitrypsin-derived C-terminal peptides might be valid as novel biomarkers to predict and/or characterise exacerbations in PiMM and PiZZ COPD patients, or to reflect the efficiency of augmentation therapy in PiZZ patients https://bit.ly/3rNJeLd.engVoRhttp://creativecommons.org/licenses/by-nc/4.0/Plasma levels of α1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patientsAtribución-NoComercial 4.0 Internacional380766749600329-202310.1183/23120541.00329-2023ERJ open researchopen access